Press release
U.S. Dog and Cat Drug Compounding Market Growing at a CAGR 7.3%, Expected to Reach US$ 573.0 Million by 2031
U.S. Dog and Cat Drug Compounding
U.S. Dog and Cat Drug Compounding Market is projected to grow at a CAGR of 7.3% from 2023 to 2031 and reach more than US$ 573.0 Mn by the end of 2031
Download Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85876
Overview of the U.S. Dog and Cat Drug Compounding Market
Drug compounding for pets involves the preparation of customized medications tailored to the specific needs of individual animals. This practice is essential for pets that require unique dosages, forms, or flavors not available in commercially manufactured drugs. Compounded medications are especially beneficial for treating dogs and cats with special health needs.
Top Companies:
Animal Pharm, LLC
BEST PET RX
Central Compounding Center South
Custom Med Compounding Pharmacy
Davis Islands Pharmacy
Millers Pharmacy
Mixlab, Inc.
PetMed Express, Inc.
PetScripts Pharmacy
Precision Compounding Pharmacy
The Compounding Pharmacy of America
The Pet Apothecary
Triangle Compounding Pharmacy
Wedgewood Pharmacy
Recent Developments in the Dog and Cat Drug Compounding Market
Recent advancements in the U.S. Dog and Cat Drug Compounding market include the development of new compounding techniques, improved formulations, and increased regulatory scrutiny to ensure safety and efficacy.
Key Developments:
New Compounding Techniques: Introduction of advanced compounding techniques that enhance the precision and quality of customized medications.
Improved Formulations: Development of palatable formulations and innovative delivery systems that improve medication adherence among pets.
Regulatory Oversight: Increased regulatory scrutiny and guidelines from agencies such as the FDA to ensure the safety and efficacy of compounded veterinary medications.
Telemedicine Integration: Growing integration of telemedicine services in veterinary practices, facilitating easier access to compounded medications.
Pharmacy Collaborations: Collaborations between veterinary compounding pharmacies and veterinary clinics to streamline the prescription and preparation process.
Key Drivers of the U.S. Dog and Cat Drug Compounding Market
Several factors are propelling the growth of the U.S. Dog and Cat Drug Compounding market. These include the rising prevalence of chronic health conditions in pets, increasing pet ownership, advancements in veterinary medicine, and the need for personalized treatment options.
Key Drivers:
Chronic Health Conditions: The rising prevalence of chronic and complex health conditions in dogs and cats, such as diabetes, cancer, and epilepsy, that require customized treatment plans.
Pet Ownership: Increasing pet ownership and the humanization of pets, leading to greater demand for specialized veterinary care and medications.
Veterinary Medicine Advancements: Innovations in veterinary medicine and compounding techniques that improve the efficacy and safety of compounded medications.
Personalized Treatment: The need for personalized treatment options for pets with specific health needs, allergies, or sensitivities to standard medications.
Consumer Awareness: Growing awareness among pet owners about the benefits of compounded medications and their role in improving pet health and quality of life.
Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85876
Future Outlook
The future of the U.S. Dog and Cat Drug Compounding market looks promising, with ongoing advancements in compounding techniques, rising demand for personalized veterinary care, and supportive regulatory frameworks. Industry stakeholders must focus on innovation, regulatory compliance, and quality assurance to fully capitalize on market opportunities.
Market Segmentation
Product
Anti-infective Drugs
Anti-inflammatory Drugs
CNS Agents
GI Drugs
Others (hormonal drugs, etc.)
Dosages Form
Tablets & Capsules
Powder
Solution
Others (suspension, etc.)
Route of Administration
Oral
Injectable
Topical
Others (ocular, rectal, etc.)
Animal Type
Dog
Cat
Region
North America
Europe
Asia Pacific
Middle East & Africa
South America
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=85876<ype=S
More Trending Report by Transparency Market Research:
Neurology Diagnostic and Monitoring Devices Market: https://www.globenewswire.com/news-release/2024/02/05/2823354/32656/en/Neurology-Diagnostic-and-Monitoring-Devices-Market-to-be-Reach-USD-12-4-billion-by-2031-Growing-at-7-5-CAGR-Transparency-Market-Research-Inc.html
Elderly and Disabled Assistive Devices Market: https://www.globenewswire.com/news-release/2024/01/12/2808596/32656/en/Elderly-and-Disabled-Assistive-Devices-Market-Revenue-to-Cross-USD-31-6-billion-by-2028-Transparency-Market-Research-Inc.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Dog and Cat Drug Compounding Market Growing at a CAGR 7.3%, Expected to Reach US$ 573.0 Million by 2031 here
News-ID: 3560147 • Views: …
More Releases from Transparency Market Research
Interactive Kiosks Market Outlook 2036: Surging from US$ 38.7 Billion in 2025 to …
The global interactive kiosks market was valued at US$ 38.7 Bn in 2025 and is projected to reach US$ 82.1 Bn by 2036, expanding at a CAGR of 7.2% from 2026 to 2036. The steady double-digit revenue expansion reflects rising demand for self-service technologies across retail, healthcare, banking, transportation, and government sectors.
With an installed base of approximately 13 to 16 million interactive and self-service kiosks globally, the industry is transitioning…
Construction Equipment Market Size Forecast to USD 352.3 Billion by 2036 with a …
Construction Equipment Market Outlook 2036
The global construction equipment market was valued at US$ 179.9 Billion in 2025 and is projected to reach US$ 352.3 Billion by 2036, expanding at a steady CAGR of 6.2% from 2026 to 2036. Market growth is primarily driven by rapid urbanization, large-scale infrastructure development projects, and increasing investments in residential, commercial, and industrial construction activities worldwide.
👉 Don't miss out on the latest market intelligence. Get…
Probiotics Market Expanding at 7.8% CAGR Through 2036 - By Ingredient / By Appli …
The global probiotics market was valued at US$ 11.6 Bn in 2025 and is projected to reach US$ 26.4 Bn by 2036, expanding at a CAGR of 7.8% from 2026 to 2036. The steady growth trajectory reflects rising consumer awareness of gut health, increasing preference for functional foods, and a growing preventive healthcare mindset across both developed and emerging economies.
Preview crucial insights and findings from our Report in this sample…
Global Hotels Market to Reach USD 2,694.9 Bn by 2036, Growing at 5.0% CAGR | Tra …
The global hotels market is entering a new phase of structured, technology-enabled growth, supported by strong recovery in travel demand and rising innovation across guest experience platforms. Valued at US$ 1,575.6 Bn in 2025, the market is projected to reach US$ 2,694.9 Bn by 2036, expanding at a CAGR of 5.0% from 2026 to 2036. Increasing digital innovation reshaping hotels and guest satisfaction, along with the resurgence of corporate travel…
More Releases for Compounding
Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220
A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who…
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of…
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.
Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured…
